Effects of blood pressure lowering on clinical outcomes according to baseline blood pressure and cardiovascular risk in patients with type 2 diabetes mellitus: the ADVANCE trial
The optimal blood pressure (BP) goal in patients with diabetes mellitus remains controversial. We examined whether benefits and risks of intensified antihypertensive therapy in diabetes mellitus are influenced by either baseline BP or cardiovascular disease (CVD) risk. We studied 10 948 people with...
Những tác giả chính: | Rahman, F, McEvoy, J, Ohkuma, T, Marre, M, Hamet, P, Harrap, S, Mancia, G, Rodgers, A, Selvin, E, Williams, B, Muntner, P, Chalmers, J, Woodward, M |
---|---|
Định dạng: | Journal article |
Được phát hành: |
American Heart Association
2019
|
Những quyển sách tương tự
-
Side-effects and tolerability of combination blood pressure lowering according to blood pressure levels – an analysis of the PROGRESS and ADVANCE trials
Bằng: Atkins, A, et al.
Được phát hành: (2017) -
Response of 1,5‐anhydroglucitol level to intensive glucose‐ and blood‐pressure lowering interventions, and its associations with clinical outcomes in the ADVANCE trial
Bằng: Selvin, E, et al.
Được phát hành: (2019) -
Prognostic value of variability in systolic blood pressure related to vascular events and premature death in type 2 diabetes mellitus: The ADVANCE-ON study
Bằng: Ohkuma, T, et al.
Được phát hành: (2017) -
The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials
Bằng: Czernichow, S, et al.
Được phát hành: (2011) -
Blood pressure variables and cardiovascular risk: new findings from ADVANCE.
Bằng: Kengne, A, et al.
Được phát hành: (2009)